The influence of organisational management on door-to-needle times for fibrinolytic treatment.

Acute stroke Cambios organizativos Door-to-needle time Ictus agudo Intravenous thrombolysis Organisational changes Protocolos Protocols Tiempo puerta-aguja Trombolisis intravenosa

Journal

Neurologia
ISSN: 2173-5808
Titre abrégé: Neurologia (Engl Ed)
Pays: Spain
ID NLM: 101778590

Informations de publication

Date de publication:
Jun 2023
Historique:
received: 22 06 2020
accepted: 05 10 2020
medline: 5 6 2023
pubmed: 17 7 2022
entrez: 16 7 2022
Statut: ppublish

Résumé

Door-to-needle time (DNT) has been established as the main indicator in code stroke protocols. According to the 2018 guidelines of the American Heart Association/American Stroke Association, DNT should be less than 45minuts; therefore, effective and revised pre-admission and in-hospital protocols are required. We analysed organisational changes made between 2011 and 2019 and their influence on DNT and the clinical progression of patients treated with fibrinolysis. We collected data from our centre, stored and monitored under the Master Plan for Cerebrovascular Disease of the regional government of Catalonia. Among other measures, we analysed the differences between years and differences derived from the implementation of the Helsinki model. The study included 447 patients, and we observed significant differences in DNT between different years. Pre-hospital code stroke activation, recorded in 315 cases (70.5%), reduced DNT by a median of 14minutes. However, the linear regression model only showed an inversely proportional relationship between the adoption of the Helsinki code stroke model and DNT (beta coefficient, -0.42; P<.001). The removal of vascular neurologists after the adoption of the Helsinki model increased DNT and the 90-day mortality rate. DNT is influenced by the organisational model. In our sample, the application of the Helsinki model, the role of the lead vascular neurologist, and notification of code stroke by pre-hospital emergency services are key factors for the reduction of DNT and the clinical improvement of the patient.

Identifiants

pubmed: 35842131
pii: S2173-5808(22)00072-4
doi: 10.1016/j.nrleng.2020.10.010
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

313-318

Informations de copyright

Copyright © 2020 Sociedad Española de Neurología. Published by Elsevier España, S.L.U. All rights reserved.

Auteurs

M Vicente-Pascual (M)

Servicio de Neurología, Hospital Universitari Arnau de Vilanova, Lleida, Spain.

A Quilez (A)

Servicio de Neurología, Hospital Universitari Arnau de Vilanova, Lleida, Spain.

M P Gil (MP)

Servicio de Neurología, Hospital Universitari Arnau de Vilanova, Lleida, Spain.

C González-Mingot (C)

Servicio de Neurología, Hospital Universitari Arnau de Vilanova, Lleida, Spain.

D Vázquez-Justes (D)

Servicio de Neurología, Hospital Universitari Arnau de Vilanova, Lleida, Spain.

G Mauri-Capdevila (G)

Servicio de Neurología, Hospital Universitari Arnau de Vilanova, Lleida, Spain.

J Sanahuja (J)

Servicio de Neurología, Hospital Universitari Arnau de Vilanova, Lleida, Spain.

C García-Vázquez (C)

Grupo de Neurosciencias Clínica, Institut de Recerca Biomèdica de Lleida, Lleida, Spain.

F Purroy (F)

Servicio de Neurología, Hospital Universitari Arnau de Vilanova, Lleida, Spain; Grupo de Neurosciencias Clínica, Institut de Recerca Biomèdica de Lleida, Lleida, Spain. Electronic address: fpurroygarcia@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH